Tag: EAACI

Intellia Reports Positive 3-Year Lonvo-z Data in HAE Trial at EAACI Congress

Intellia Therapeutics, Inc. (NASDAQ:NTLA) has recently made headlines as one of the top genomics stocks to buy according…